Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2 is a research paper published in eLife (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 GM144890
National Institutes of Health
Grant: R01 CA172090
National Institutes of Health
Grant: R01 CA258614
National Institutes of Health
Grant: R21 CA259706
American Cancer Society
Grant: Research Scholar Grant RSG-19-166-01-TBG
American Lung Association
Grant: Lung Cancer Discovery Award 821321
Tobacco-Related Disease Research Program
Grant: Research Award T33IR6461
National Institutes of Health
Grant: 4R01CA172090-04
PDLIM2 as a cancer and chemosensitizing target
National Institutes of Health
Grant: 3R01GM144890-02S1
Administrative Supplement: Dissection of NF-kappaB regulation by the ubiquitin E3 ligase PDLIM2 in lung innate immunity and diseases
National Institutes of Health
Grant: 5R01CA258614-02
Mechanistic difference of NF-kappaB in lung physiology and tumorigenesis
National Institutes of Health
Grant: 1R21CA259706-01
Faithful mouse modeling of human lung cancer
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals